The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows...
Keep Reading →
December 21 - Hedge Funds, News - Comments
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge...
Keep Reading →
November 4 - Hedge Funds, News - Comments
In a world dominated by a pandemic, you might wonder how its affecting the 10 biggest pharmaceutical companies in the world in 2020 (click to skip ahead...
Keep Reading →
September 13 - Lists - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings...
Keep Reading →
September 9 - Hedge Funds, News - Comments
AstraZeneca plc (NYSE:AZN) could easily acquire Gilead Sciences, Inc. (NASDAQ:GILD) Headlines: Market Dynamics May Inspire AZN To Re-Engage. A $200B...
Keep Reading →
August 29 - Market Movers, Stock Analysis - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Keep Reading →
July 12 - Hedge Funds, News - Comments
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Keep Reading →
June 9 - Hedge Funds, News - Comments
Operation Warp Speed: The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates...
Keep Reading →
May 31 - Stock Analysis - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Keep Reading →
May 4 - Hedge Funds, News - Comments
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published an article with the title Recession...
Keep Reading →
March 12 - Hedge Funds, News - Comments
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Keep Reading →
January 13 - Hedge Funds, News - Comments
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018. Trends reversed...
Keep Reading →
December 6 - Hedge Funds, News - Comments
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided...
Keep Reading →
October 9 - Hedge Funds, News - Comments
At Insider Monkey we follow nearly 750 of the best-performing investors and even though many of them lost money in the last couple of months of 2018 (...
Keep Reading →
June 14 - Hedge Funds, News - Comments
The extended weekend is now over, and Wall Street is once again paying attention to the U.S. China trade war, the Indian stock market now that Modi has...
Keep Reading →
May 28 - News - Comments
Before we spend days researching a stock idea we’d like to take a look at how hedge funds and billionaire investors recently traded that stock....
Keep Reading →
March 26 - Hedge Funds, News - Comments
The market has been volatile as the Federal Reserve continues its rate hikes to normalize the interest rates. Small cap stocks have been hit hard as a...
Keep Reading →
December 12 - Hedge Funds, News - Comments
Fisher Investments was founded in 1979 by billionaire Ken Fisher. The fee-only investment adviser managed more than $100 billion in assets as of July...
Keep Reading →
November 13 - Dividend Stocks, Hedge Funds, News - Comments
Dan Loeb’s Hedge Fund Trims Number of Nominees to Campbell Soup Board (CNBC) Daniel Loeb‘s hedge fund, Third Point, has trimmed the number...
Keep Reading →
November 9 - Hedge Funds, Insider Trading - Comments
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest...
Keep Reading →
November 24 - News - Comments
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and...
Keep Reading →
November 23 - News - Comments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr. Rosenwald...
Keep Reading →
August 25 - Hedge Funds, News - Comments
1. U.S. Stock Market: “U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic...
Keep Reading →
May 12 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short...
Keep Reading →
April 12 - Lists, News - Comments
AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S. Food and Drug Administration for ZS...
Keep Reading →
March 21 - News, Stock Analysis - Comments
In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million...
Keep Reading →
March 20 - News, Stock Analysis - Comments
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression. AstraZeneca...
Keep Reading →
March 16 - News, Stock Analysis - Comments
It’s been a big week for PARP inhibitors. AstraZeneca PLC (ADR) (NYSE:AZN) just put out data from a phase 3 investigation of its lead PARP asset Lynparza...
Keep Reading →
March 15 - News, Stock Analysis - Comments
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop...
Keep Reading →
March 15 - Lists, News - Comments
AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs, as they could possess potential in curing a disease they were not initially...
Keep Reading →
March 14 - News, Stock Analysis - Comments
Hutchison China MediTech Limited and AstraZeneca plc (ADR) (NYSE:AZN) are to present data from their phase II clinical trials of Savolitinib, at the upcoming...
Keep Reading →
February 15 - News, Stock Analysis - Comments
Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from...
Keep Reading →
January 31 - News, Stock Analysis - Comments
The US Food and Drug Administration (FDA) has confirmed that Symbicort (budesonide/formoterol) Inhalation Aerosol is worth being granted paediatric exclusivity...
Keep Reading →
January 30 - News, Stock Analysis - Comments
AstraZeneca plc (ADR) (NYSE:AZN) share price could receive a major boost on the company pursuing a label expansion for its blockbuster Tagrisso. The drug...
Keep Reading →
January 3 - News, Stock Analysis - Comments
AstraZeneca plc (ADR) (NYSE:AZN)’s chief executive officer has said that the long negotiation process that the NHS undertakes with drugmakers before...
Keep Reading →
December 30 - News, Stock Analysis - Comments
Today, we present you 10 famous corporate whistleblowers in publicly-traded companies. It takes a lot of guts for an individual to stand up against huge...
Keep Reading →
December 30 - Lists, News - Comments
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined...
Keep Reading →
December 9 - Hedge Funds, News - Comments
AstraZeneca plc (ADR) (NYSE:AZN) has recently unveiled how it plans to transform its US Commercial segment as part of its broader growth strategy. “...
Keep Reading →
December 9 - News, Stock Analysis - Comments
Tagrisso, a lung cancer med from AstraZeneca plc (ADR) (NYSE:AZN) is already in early approval based on mid-stage studies, which demonstrates the possibility...
Keep Reading →
December 7 - News, Stock Analysis - Comments
AstraZeneca plc (ADR) (NYSE:AZN) plans to cut some back office jobs in the U.K. as the company works toward cost-cutting and operation consolidation....
Keep Reading →
December 6 - News, Stock Analysis - Comments
The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY...
Keep Reading →
November 23 - News, Stock Analysis - Comments
AstraZeneca PLC (ADR) (NYSE:AZN) will no longer seek early regulatory review of its drug candidate durvalumab in patients with head and neck cancers....
Keep Reading →
November 11 - Earnings Report, News, Stock Analysis - Comments
AstraZeneca plc (ADR) (NYSE:AZN) has recently released encouraging data from SOLO-2, a phase 3 clinical trial evaluating the efficacy of Lynparza (olaparib...
Keep Reading →
October 27 - News, Stock Analysis - Comments
AstraZeneca Plc (ADR) (NYSE:AZN) has once again reiterated its intention to focus on core therapeutic areas with the signing of a new commercialization...
Keep Reading →
October 14 - News, Stock Analysis - Comments
Markets have opened at shaky note with major indices treading on margin. International Monetary Fund declared the global economic recovery to be ‘weak...
Keep Reading →
October 4 - News - Comments
It’s a red day on Wall Street, as all three major indexes are off by around 0.35%, potentially due to some market participants remaining on the...
Keep Reading →
October 3 - Market Movers, News - Comments
The US stock market is trading lower on Wednesday amid lower oil prices and in-line August payroll figures reported by Automatic Data Processing. In...
Keep Reading →
August 31 - Earnings Report, News - Comments
Crude futures are below $42 per barrel this morning as traders brace for the upcoming rig count release on Friday. That news affects some of the companies...
Keep Reading →
July 28 - Market Movers, News - Comments
The Brexit is looming and, no matter how cute a name we can come up with, the issue is as serious as can be. On June 23, Britain will hold a referendum...
Keep Reading →
June 13 - Hedge Fund Analysis, Hedge Funds - Comments
The markets are off to a slow start today amid a report from the Labor Department which shows that over the last week, jobless claims surged to their...
Keep Reading →
May 12 - Market Movers, News - Comments